[1] |
Zhong H, Song Z, Chen W, et al. Chronic urticaria in Chinese population: a hospital⁃based multicenter epidemiological study[J]. Allergy, 2014,69(3):359⁃364. doi: 10.1111/all.12338.
|
[2] |
李邻峰, 王楷. 慢性难治性荨麻疹的诊断及治疗策略[J]. 中华皮肤科杂志, 2017,50(1):1⁃4. doi: 10.3760/cma.j.issn.0412⁃4030.2017.01.001.
|
[3] |
陈曙光, 翟志芳, 宋志强, 等. 自体全血注射治疗对自体血清皮肤试验阳性的慢性自发性荨麻疹的疗效观察[J]. 中华皮肤科杂志, 2012,45(7):470⁃473. doi: 10.3760/cma.j.issn.0412⁃4030.2012.07.004.
|
[4] |
Kitsioulis NA, Xepapadaki P, Roussaki⁃Schulze A, et al. Effectiveness of autologous whole⁃blood injections in patients with refractory chronic spontaneous urticaria[J]. Int Arch Allergy Immunol, 2017,172 (3):161⁃166. doi: 10.1159/000458152.
|
[5] |
Staubach P, Onnen K, Vonend A, et al. Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo⁃controlled trial[J]. Dermatology, 2006,212(2):150⁃159. doi: 10.1159/000090656.
|
[6] |
You HS, Cho HH, Kim WJ, et al. Autologous whole blood injection for the treatment of antihistamine⁃resistant chronic spontaneous urticaria[J]. Ann Dermatol, 2015,27(6):784⁃786. doi: 10.5021/ad.2015.27.6.784.
|
[7] |
Saini SS, Omachi TA, Trzaskoma B, et al. Effect of omalizumab on blood basophil counts in patients with chronic idiopathic/spontaneous urticaria[J]. J Invest Dermatol, 2017,137(4):958⁃961. doi: 10.1016/j.jid.2016.11.025.
|
[8] |
Metz M, Staubach P, Bauer A, et al. Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI⁃positive cells in the skin[J]. Theranostics, 2017,7(5):1266⁃1276. doi: 10.7150/thno.18304.
|
[9] |
Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria[J]. Allergy, 2018,73(7):1393⁃1414. doi: 10.1111/all.13397.
|
[10] |
Konstantinou GN, Asero R, Maurer M, et al. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria[J]. Allergy, 2009,64(9):1256⁃1268. doi: 10.1111/j. 1398⁃9995.2009.02132.x.
|
[11] |
Deza G, Bertolín⁃Colilla M, Pujol RM, et al. Basophil FcεRI in chronic spontaneous urticaria: a potential immunological predictor of response to omalizumab therapy[J]. Acta Derm Venereol, 2017,97(6):698⁃704. doi: 10.2340/00015555⁃2654.
|
[12] |
Christensen CU, Vestergaard C, Hoffmann HJ. Activation markers CD63 and CD203c are upregulated in chronic urticaria[J]. Ann Dermatol, 2013,25 (4):522⁃523. doi: 10.5021/ad.2013.25.4.522.
|
[13] |
Frezzolini A, Provini A, Teofoli P, et al. Serum⁃induced basophil CD63 by means of a tricolour flow cytometric method for the in vitro diagnosis of chronic urticaria[J]. Allergy, 2006,61(9):1071⁃1077. doi: 10.1111/j.1398⁃9995.2006.01033.x.
|
[14] |
MacGlashan D. Auto⁃antibodies to IgE and FceRI and the natural variability of SYK in basophils[J/OL]. J Allergy Clin Immunol, 2018. pii: S0091⁃6749(18)30781⁃4. [2018⁃06⁃21]. https://www.jacionline.org/article/S0091⁃6749(18)30781⁃4/pdf. doi: 10.1016/j.jaci.2018.05.019. [published online ahead of print May 31,2018].
|
[15] |
Konstantinou GN, Asero R, Maurer M, et al. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria[J]. Allergy, 2009,64(9):1256⁃1268. doi: 10.1111/j.1398⁃ 9995.2009.02132.x.
|
[16] |
Grattan CE, Dawn G, Gibbs S, et al. Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity[J]. Clin Exp Allergy, 2003,33(3):337⁃341.
|
[17] |
Kocatürk E, Aktaş S, Türkoglu Z, et al. Autologous whole blood and autologous serum injections are equally effective as placebo injections in reducing disease activity in patients with chronic spontaneous urticaria: a placebo controlled, randomized, single⁃blind study[J]. J Dermatolog Treat, 2012,23(6):465⁃471. doi: 10.3109/09546634.2011.593485.
|
[18] |
Kocatürk E, Aktaş S, Türkoğlu Z, et al. Autologous whole blood and autologous serum injections are equally effective as placebo injections in reducing disease activity in patients with chronic spontaneous urticaria: a placebo controlled, randomized, single⁃blind study[J]. J Dermatolog Treat, 2012,23(6):465⁃471. doi: 10.3109/09546634.2011.593485.
|
[19] |
中华医学会皮肤性病学分会免疫学组. 中国荨麻疹诊疗指南(2014版)[J]. 中华皮肤科杂志, 2014,47(7):514⁃516. doi: 10.3760/cma.j.issn.0412⁃4030.2014.07.019.
|
[20] |
Godse K, De A, Zawar V, et al. Consensus statement for the diagnosis and treatment of urticaria: a 2017 update[J]. Indian J Dermatol, 2018,63 (1):2. doi: 10.4103/ijd.IJD_308_17.
|
[21] |
Chung WH, Chu CY, Huang YH, et al. Taiwanese Dermatological Association consensus for the definition, classification, diagnosis, and management of urticaria[J]. J Formos Med Assoc, 2016,115(11):968⁃980. doi: 10.1016/j.jfma.2015.09.009.
|
[22] |
Sheikhi A, Azarbeig M, Karimi H. Autohemotherapy in chronic urticaria: what could be the autoreactive factors and curative mechanisms?[J]. Ann Dermatol, 2014,26(4):526⁃527. doi: 10. 5021/ad.2014.26.4.526.
|
[23] |
MacGlashan DWJr. Relationship between spleen tyrosine kinase and phosphatidylinositol 5′ phosphatase and secretion from human basophils in the general population[J]. J Allergy Clin Immunol, 2007,119(3):626⁃633. doi: 10.1016/j.jaci.2006.09.040.
|
[24] |
Chen Q, Zhai Z, Xu J, et al. Basophil CD63 in chronic spontaneous urticaria: correlation with allergic sensitization, serum autoreactivity and basophil reactivity[J]. J Eur Acad Dermatol Venereol, 2017,31(3):463⁃468. doi: 10.1111/jdv.13912.
|
[25] |
Greer AM, Wu N, Putnam AL, et al. Serum IgE clearance is facilitated by human FcεRI internalization[J]. J Clin Invest, 2014,124(3):1187⁃1198. doi: 10.1172/JCI68964.
|
[26] |
Jörg L, Pecaric⁃Petkovic T, Reichenbach S, et al. Double⁃blind placebo⁃controlled trial of the effect of omalizumab on basophils in chronic urticaria patients[J]. Clin Exp Allergy, 2018,48(2):196⁃204. doi: 10.1111/cea.13066.
|